ZA945236B - Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders - Google Patents

Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders

Info

Publication number
ZA945236B
ZA945236B ZA945236A ZA945236A ZA945236B ZA 945236 B ZA945236 B ZA 945236B ZA 945236 A ZA945236 A ZA 945236A ZA 945236 A ZA945236 A ZA 945236A ZA 945236 B ZA945236 B ZA 945236B
Authority
ZA
South Africa
Prior art keywords
preparation
treatment
obsessive
indol
pyridinyl
Prior art date
Application number
ZA945236A
Other languages
English (en)
Inventor
Sathapana Kongsamut
Craig Paul Smith
Ann Theresa Woods
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA945236B publication Critical patent/ZA945236B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA945236A 1993-07-19 1994-07-18 Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders ZA945236B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/092,848 US5356910A (en) 1993-07-19 1993-07-19 Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder

Publications (1)

Publication Number Publication Date
ZA945236B true ZA945236B (en) 1995-02-28

Family

ID=22235450

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945236A ZA945236B (en) 1993-07-19 1994-07-18 Use of N-(pyridinyl)-1H-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders

Country Status (21)

Country Link
US (1) US5356910A (fr)
EP (1) EP0635269B1 (fr)
JP (1) JP2807633B2 (fr)
KR (1) KR100325276B1 (fr)
AT (1) ATE186215T1 (fr)
AU (1) AU673747B2 (fr)
CA (1) CA2128312C (fr)
CZ (1) CZ288593B6 (fr)
DE (1) DE69421457T2 (fr)
DK (1) DK0635269T3 (fr)
EG (1) EG20716A (fr)
ES (1) ES2138017T3 (fr)
GR (1) GR3032292T3 (fr)
HU (1) HU217063B (fr)
MX (1) MX9405209A (fr)
NO (1) NO306597B1 (fr)
NZ (1) NZ264015A (fr)
PL (1) PL304335A1 (fr)
RU (1) RU2164795C2 (fr)
TW (1) TW349864B (fr)
ZA (1) ZA945236B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
CN1184969C (zh) * 1995-07-27 2005-01-19 阿温蒂斯药物公司 未取代和取代的n－(吡咯－1－基)吡啶胺作为抗惊厥药的用途
HUP9802413A3 (en) * 1995-07-27 2002-02-28 Aventis Pharmaceuticals Inc Br Use of n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents and for the preparation of a pharmaceutical composition for the treatment of convulsions
JP4608723B2 (ja) * 1999-03-10 2011-01-12 東ソー株式会社 置換インドール誘導体の製造方法
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2892022B1 (fr) * 2005-10-19 2008-01-04 Urogene Sa Traitement des symptomes de l'irritation de la vessie
FR2892021B1 (fr) * 2005-10-19 2008-01-04 Urogene Traitement de l'incontinence urinaire d'effort et mixte
FR2897614B1 (fr) * 2006-02-20 2008-05-23 Urogene Forme cristalline du chlorhydrate de la besipirdine, procedes de preparation et utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
DE3852335T2 (de) 1987-04-24 1995-05-11 Hoechst Roussel Pharma N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel.
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5185350A (en) 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles

Also Published As

Publication number Publication date
PL304335A1 (en) 1995-01-23
HUT69709A (en) 1995-09-28
KR950002761A (ko) 1995-02-16
US5356910A (en) 1994-10-18
RU2164795C2 (ru) 2001-04-10
HU9402124D0 (en) 1994-09-28
NZ264015A (en) 1997-07-27
EP0635269B1 (fr) 1999-11-03
DK0635269T3 (da) 2000-04-25
CZ173094A3 (en) 1995-02-15
NO942695D0 (no) 1994-07-18
MX9405209A (es) 1995-01-31
CA2128312C (fr) 2004-09-28
RU94026084A (ru) 1996-08-27
GR3032292T3 (en) 2000-04-27
JP2807633B2 (ja) 1998-10-08
AU673747B2 (en) 1996-11-21
NO306597B1 (no) 1999-11-29
KR100325276B1 (ko) 2002-09-25
DE69421457D1 (de) 1999-12-09
ATE186215T1 (de) 1999-11-15
DE69421457T2 (de) 2000-05-04
TW349864B (en) 1999-01-11
EP0635269A1 (fr) 1995-01-25
HU217063B (hu) 1999-11-29
NO942695L (no) 1995-01-20
EG20716A (en) 1999-12-29
CA2128312A1 (fr) 1995-01-20
AU6753194A (en) 1995-01-27
ES2138017T3 (es) 2000-01-01
JPH0753376A (ja) 1995-02-28
CZ288593B6 (cs) 2001-07-11

Similar Documents

Publication Publication Date Title
IL127244A0 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
HU9600834D0 (en) Quinazoline derivatives
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
PL314086A1 (en) Novel (r)-8-fluoro-3-n,n-substituted amino 3,4-dihydro 5-carbamoyl-2h-1-bezopyranes
AP9701041A0 (en) Pyridylpyrrole compounds.
AU5752194A (en) Benzimidazole compounds, their use and preparation
JO1613B1 (en) Derivatives of n - (3-hydroxy-4-piperidnil) dihydrobenzofuran, dihydro-2u-benzopyran or dihydro-benzodoxine) carboxymide
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
WO1999012532A3 (fr) Derives de piperidine contre la malaria
WO1997005862A3 (fr) Utilisation des aminoacides de base et de leurs derives pour abaisser les taux de ceramide
HU9402124D0 (en) Use of n-(pyridinyl)-1h-indoll-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders
CA2282279A1 (fr) Atropisomeres de 3-heteroaryl-4(3h)-quinazolinones pour le traitement des troubles neurodegeneratifs et des troubles lies a un traumatisme du systeme nerveux central
TW285640B (fr)
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
GB8823605D0 (en) Therapeutic agents
AU6046096A (en) Methods of treating microbial infections
HRP20030696A2 (en) GlyT-1 INHIBITORS
WO1994016705A3 (fr) Composition pharmaceutique contenant de la 5-morpholinomethyle-3-(4-chlorobenzylideneamine)-2-oxazolidinone et son utilisation pour le traitement des troubles du snc